Sloan-K. Cancer Center

We have finished the collaboration with the Memorial Sloan-Kettering Cancer Center of New York by financing a research on Retinoblastoma managed by Dr. David Abramson and his team. This is the most common malignant cancer of the eye in children. For more than 100 years the only treatment was the removal of the eye; but in this new research, Dr Abramson has demonstrated that this technique is no longer necessary and that 95% of the eyes treated can be saved.

Share on social networks:

Other projects that may interest you

Fent Amics

i4c has sponsored the charity journey Fent Amics that has been organized by Down Catalunya at PortAventura World for 10 years. This event raises funds for Down Catalunya and its…
see project

Research program at Uppsala University

The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients…
see project